COLM Stock Analysis: Columbia Sportswear | NASDAQ
Apparel Manufacturing | NASDAQ, USA | Market Cap: 2.894m USD | 12M Return: 13.4% | US1985161066 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 39.0M
EPS Trend: -96.6%
Qual. Beats: 0
Rev. Trend: -50.6%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Columbia Sportswear Company (NASDAQ: COLM) is a global outdoor and active lifestyle apparel and footwear company headquartered in Portland, Oregon, founded in 1938. The company designs, develops, markets, and distributes products across apparel, accessories, equipment, and footwear for activities including hiking, trail running, snow sports, fishing, and hunting, operating in the United States, Latin America, Asia Pacific, Europe, the Middle East, Africa, and Canada.
The company operates a multi-brand portfolio under the Columbia, Mountain Hardwear, PRANA, and SOREL labels, and reaches customers through two main channels: a wholesale network that includes specialty outdoor retailers, sporting goods chains, department stores, and international distributors, and a direct-to-consumer channel comprising branded retail stores, outlet locations, brand-specific e-commerce sites, and shop-in-shop retail locations. As a member of the Consumer Discretionary sector within the Apparel, Accessories & Luxury Goods sub-industry, Columbia competes in a segment where brand portfolio diversification and the balance between wholesale and direct-to-consumer distribution are central to long-term margin and growth strategy.
- Wholesale channel destocking pressures gross margins
- Direct-to-consumer expansion lifts operating margins
- Tariffs on Asian-sourced production raise input costs
| Net Income: 206.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 2.58 > 1.0 |
| NWC/Revenue: 32.80% < 20% (prev 33.19%; Δ -0.39% < -1%) |
| CFO/TA 0.14 > 3% & CFO 383.2m > Net Income 206.0m |
| Net Debt (-163.4m) to EBITDA (331.3m): -0.49 < 3 |
| Current Ratio: 2.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (52.0m) vs 12m ago -5.11% < -2% |
| Gross Margin: 52.02% > 18% (prev 50.29%; Δ 1.74% > 0.5%) |
| Asset Turnover: 119.8% > 50% (prev 118.1%; Δ 1.70% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.40 (Total Current Assets 1.87b - Total Current Liabilities 748.5m) / Total Assets 2.80b |
| B: 0.59 (Retained Earnings 1.66b / Total Assets 2.80b) |
| C: 0.10 (EBIT TTM 274.9m / Avg Total Assets 2.84b) |
| D: 1.34 (Book Value of Equity 1.60b / Total Liabilities 1.20b) |
| Altman-Z'' = 6.61 = AAA |
| DSRI: 0.94 (Receivables 271.3m/290.6m, Revenue 3.41b/3.41b) |
| GMI: 0.97 (GM 50.29% / 52.02%) |
| AQI: 0.94 (AQ_t 0.09 / AQ_t-1 0.10) |
| SGI: 1.00 (Revenue 3.41b / 3.41b) |
| TATA: -0.06 (NI 206.0m - CFO 383.2m) / TA 2.80b) |
| Beneish M = -3.16 (Cap -4..+1) = AA |
As of October 12, 2026, the stock is trading at USD 57.04 with a total of 595,060 shares traded. Over the past week, the price has changed by -0.40%, over one month by +1.75%, over three months by -9.88% and over the past year by +13.36%.
Current recommended Stop Loss: 54.80 (which is 3.9% or 1.5 ATR below the current price).
Columbia Sportswear has received a consensus analysts rating of 3.38. Therefore, it is recommended to hold COLM.
- StrongBuy: 2
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 69.8 | 22.4% |
P/E Trailing = 14.9947
P/E Forward = 12.7065
P/S = 0.8494
P/B = 1.8149
P/EG = 2.186
Revenue TTM = 3.41b USD
EBIT TTM = 274.9m USD
EBITDA TTM = 331.3m USD
Long Term Debt = 377.2m USD (estimated: total debt 461.2m - short term 84.0m)
Short Term Debt = 84.0m USD (from shortTermDebt, last quarter)
Debt = 461.2m USD (from shortLongTermDebtTotal, last quarter) (leases 461.2m already included)
Net Debt = -163.4m USD (calculated: Debt 461.2m - CCE 624.6m)
Enterprise Value = 2.73b USD (2.89b + Debt 461.2m - CCE 624.6m)
Interest Coverage Ratio = unknown (Ebit TTM 274.9m / Interest Expense TTM 0.0)
EV/FCF = 8.50x (Enterprise Value 2.73b / FCF TTM 321.3m)
FCF Yield = 11.77% (FCF TTM 321.3m / Enterprise Value 2.73b)
FCF Margin = 9.43% (FCF TTM 321.3m / Revenue TTM 3.41b)
Net Margin = 6.05% (Net Income TTM 206.0m / Revenue TTM 3.41b)
Gross Margin = 52.02% ((Revenue TTM 3.41b - Cost of Revenue TTM 1.63b) / Revenue TTM)
Gross Margin QoQ = 58.34% (prev 50.70%)
Tobins Q-Ratio = 0.98 (Enterprise Value 2.73b / Total Assets 2.80b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 461.2m)
Taxrate = 25.05% (68.9m / 274.9m)
NOPAT = 206.0m (EBIT 274.9m * (1 - 25.05%))
Current Ratio = 2.49 (Total Current Assets 1.87b / Total Current Liabilities 748.5m)
Debt / Equity = 0.29 (Debt 461.2m / totalStockholderEquity, last quarter 1.60b)
Debt / EBITDA = -0.49 (Net Debt -163.4m / EBITDA 331.3m)
Debt / FCF = -0.51 (Net Debt -163.4m / FCF TTM 321.3m)
Total Stockholder Equity = 1.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.24% (Net Income 206.0m / Total Assets 2.80b)
RoE = 12.58% (Net Income TTM 206.0m / Total Stockholder Equity 1.64b)
RoCE = 13.64% (EBIT 274.9m / Capital Employed (Equity 1.64b + L.T.Debt 377.2m))
RoIC = 10.50% (NOPAT 206.0m / Invested Capital 1.96b)
WACC = 7.02% (E(2.89b)/V(3.36b) * Re(8.14%) + D(461.2m)/V(3.36b) * Rd(0.0%) * (1-Tc(0.25)))
Discount Rate = 8.14% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.55 | Cagr: -6.18%
[DCF] Terminal Value 77.97% ; FCFF base≈295.7m ; Y1≈338.9m ; Y5≈498.8m
[DCF] Fair Price = 149.8 (EV 7.51b - Net Debt -163.4m = Equity 7.67b / Shares 51.2m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -96.64 | EPS CAGR: -15.91% | SUE: 0.0 | # QB: 0
Revenue Correlation: -50.56 | Revenue CAGR: -1.09% | SUE: 0.56 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.28 | Chg30d=-17.36% | Revisions=-70% | Analysts=8
EPS current Year (2026-12-31): EPS=4.67 | Chg30d=+21.24% | Revisions=+55% | GrowthEPS=+44.2% | GrowthRev=+1.8%
EPS next Year (2027-12-31): EPS=4.19 | Chg30d=-1.03% | Revisions=-10% | GrowthEPS=-10.4% | GrowthRev=+3.1%
[Analyst] Revisions Ratio: -8% (up=10, down=12)